68 - Bacteriophage: From Bench to Bedside

Thursday, October 20, 2022

1:45 PM – 3:00 PM US ET

Location: 152 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Cecilia Tran, PharmD

Research Scientist
Houston Methodist Hospital
Houston, TX, United States

Disclosure(s): No financial relationships to disclose
Lynn El Haddad, PhD

Assistant Professor
Medicine
University of Florida, Gainesville
Gainesville, FL, United States

Disclosure(s): No financial relationships to disclose

Faculty(s)

Jeremy Barr, PhD

Senior Lecturer & Group Leader
Monash University
Prahran, Australia

Disclosure(s): No financial relationships to disclose

Slides
Bryan Lenneman, PhD

Postdoctoral Associate
Massachusetts Institute of Technology

Disclosure(s): No financial relationships to disclose

Slides
Austen Terwillinger, PhD

Laboratory Director
Baylor College of Medicine
Houston, TX, United States

Disclosure(s): No financial relationships to disclose

Slides

Disclosure(s):

Cecilia Tran, PharmD: No financial relationships to disclose

Lynn El Haddad, PhD: No financial relationships to disclose

Jeremy Barr, PhD: No financial relationships to disclose

Bryan Lenneman, PhD: No financial relationships to disclose

Austen Terwillinger, PhD: No financial relationships to disclose

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

outline the specific interactions between phages and their hosts and how these interactions can impact therapy;
discuss how CRISPR-Cas technology can enhance bacteriophage and their potential place in therapy;
describe the clinical experience of phage therapy for treatment of multidrug-resistant organisms

Presentations:

1:45 PM – 2:10 PM US ET

Fundamentally Applied Phage Biology
Speaker: Jeremy Barr, PhD – Monash University
2:10 PM – 2:35 PM US ET

Bacteriophage and CRISPR: Turning the Tables on Multidrug-Resistant Bacteria
Speaker: Bryan Lenneman, PhD – Massachusetts Institute of Technology
2:35 PM – 3:00 PM US ET

The TAILOR 12: Addressing the Natural History of Infection
Speaker: Austen Terwillinger, PhD – Baylor College of Medicine